THE EFFECT OF ANTI-PD-1 THERAPY ON MEDIAN OVERALL SURVIVAL AND PROGRESSION FREE SURVIVAL IN GLIOBLASTOMA MULTIFORME PATIENTS WITH CERTAIN TUMOR MARKERS

被引:1
作者
Paracha, Awais [1 ]
Campian, Jian [2 ]
机构
[1] St Louis Univ, Sch Med, St Louis, MO USA
[2] Washington Univ, St Louis, MO 63110 USA
关键词
D O I
10.1136/jitc-2020-SITC2020.0214
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
214
引用
收藏
页码:A128 / A128
页数:1
相关论文
共 6 条
  • [1] CAR T Cell Therapy: A Game Changer in Cancer Treatment
    Almasbak, Hilde
    Aarvak, Tanja
    Vemuri, Mohan C.
    [J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 2016
  • [2] Isocitrate Dehydrogenase (IDH) 1/2 Mutations as Prognostic Markers in Patients With Glioblastomas
    Chen, Jun-Rui
    Yao, Yu
    Xu, Hong-Zhi
    Qin, Zhi-Yong
    [J]. MEDICINE, 2016, 95 (09)
  • [3] Glioblastoma: Overview of Disease and Treatment
    Davis, Mary Elizabeth
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2016, 20 (05) : 2 - 8
  • [4] TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma
    Mosrati, Mohamed Ali
    Malmstrom, Annika
    Lysiak, Malgorzata
    Krysztofiak, Adam
    Hallbeck, Martin
    Milos, Peter
    Hallbeck, Anna-Lotta
    Bratthall, Charlotte
    Strandeus, Michael
    Stenmark-Askmalm, Marie
    Soderkvist, Peter
    [J]. ONCOTARGET, 2015, 6 (18): : 16663 - 16673
  • [5] Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
    Stupp, R
    Mason, WP
    van den Bent, MJ
    Weller, M
    Fisher, B
    Taphoorn, MJB
    Belanger, K
    Brandes, AA
    Marosi, C
    Bogdahn, U
    Curschmann, J
    Janzer, RC
    Ludwin, SK
    Gorlia, T
    Allgeier, A
    Lacombe, D
    Cairncross, JG
    Eisenhauer, E
    Mirimanoff, RO
    Van Den Weyngaert, D
    Kaendler, S
    Krauseneck, P
    Vinolas, N
    Villa, S
    Wurm, RE
    Maillot, MHB
    Spagnolli, F
    Kantor, G
    Malhaire, JP
    Renard, L
    De Witte, O
    Scandolaro, L
    Vecht, CJ
    Maingon, P
    Lutterbach, J
    Kobierska, A
    Bolla, M
    Souchon, R
    Mitine, C
    Tzuk-Shina, T
    Kuten, A
    Haferkamp, G
    de Greve, J
    Priou, F
    Menten, J
    Rutten, I
    Clavere, P
    Malmstrom, A
    Jancar, B
    Newlands, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10) : 987 - 996
  • [6] The Predictive Value of Tumor Mutation Burden on Efficacy of Immune Checkpoint Inhibitors in Cancers: A Systematic Review and Meta-Analysis
    Wu, Yongfeng
    Xu, Jinming
    Du, Chengli
    Wu, Yihua
    Xia, Dajing
    Lv, Wang
    Hu, Jian
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9